04E-Meeting abstract in rivista

04E-Meeting abstract in rivista Home page tipologia

Sfoglia

Iscriviti a questa tipologia per ricevere ogni giorno la notifica via e-mail di nuovi arrivi RSS Feed RSS Feed RSS Feed
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 2.199
TitoloData di depositoAutore(i)
Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights24-ott-2020Salvetti C, Vitale C, Griggio V, Drandi D, Bonello L, Cavallo F, Bomben R, Gattei V, Zamò A, Coscia M
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib24-ott-2020Perutelli F, Griggio V, Vitale C, Mauro FR, Salvetti C, Boccellato E, Pietrasanta D, Vincelli ID, Ghia P, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M
Treatment of chronic lymphocytic leukemia in the new drugs era: the state of art in the Italian landscape24-ott-2020Morelli F, Innocenti I, Autore F, Fresa F, Tomasso A, Piciocchi A, Frustaci AM, Trentin L, Mauro FR, Schiattone L, Visentin A, Del Poeta G, Reda G, Rigolin GM, Ibatici A, Ciolli S, Vitale C, Sportoletti P, Murru R, Levato L, Gentile M, D’Arena G, Coscia M, Villa MR, Fontana R, Efremov D, Tedeschi A, Scarfò L, Cuneo A, Foà R, Laurenti L
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia24-ott-2020Griggio V, Vitale C, Salvetti C, Mauro FR, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M
Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs24-ott-2020Vitale C, Salvetti C, Griggio V, Scamuffa MC, Zamprogna G, Visentin A, Cassin R, Laurenti L, Murru R, Rivela P, Marchetti M, Gentile M, Pennese E, Reda G, Trentin L, Tedeschi A, Mauro FR, Foà R, Boccadoro M, Coscia M
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells24-ott-2020Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target24-ott-2020Griggio V, Vitale C, Todaro M, Riganti C, Kopecka J, Salvetti C, Bomben R, Dal Bo M, Rossi D, Pozzato G, Marchetti M, Omedé P, Bonello L, Kodipad AA, Laurenti L, Del Poeta G, Mauro FR, Bernardi R, Gattei V, Gaidano G, Foa’ R, Massaia M, Boccadoro M, Coscia M
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells24-ott-2020Vitale, Candida; Todaro, Maria; Griggio, Valentina; Salvetti, Chiara; Riganti, Chiara; Landesman, Yosef; Boccadoro, Mario; Coscia, Marta
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells24-ott-2020Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
INVESTIGATING LINK BETWEEN INTELLECTUAL CAPITAL AND BUSINESS MODEL: A SYSTEMATIC LITERATURE REVIEW15-ott-2020Baima Gabriele, Forliano Canio, Santoro Gabriele, Bresciani Stefano
Efficacy of transjugular intrahepatic porto systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease9-set-2020Paola Ponzo, Martina Rizza, Daniela Campion, Ilaria Giovo, Michele Roma, Felice Rizzi, Alessandra Risso, Gian Paolo Caviglia, Giorgio Maria Saracco, Carlo Alessandria
Terlipressin vs noradrenalin for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: 1 5-year retrospective analysis9-set-2020Ilaria Giovo, Martina Rizzo, Paola Ponzo, Daniela Campion, Michele Roma, Felice Brizzi, Alessandra Risso, Gian Paolo Caviglia, Federico Balzola, Silvia Martini, Maria Torrani Cerenzia, Giorgio Maria Saracco, Carlo Alessandria
Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality?9-set-2020Daniela Campion, Martina Rizzo, Paola Ponzo, Alessandro Risso, Ilaria Giovo, Felice Rizzi, Michele Roma, Alessandra Risso, Paola Caropreso, Gian Paolo Caviglia, Loredana Colla, Luigi Biancone, Aldo Manca, Giulio Mengozzi, Giorgio Maria Saracco, Carlo Alessandria
Differences between a traditional and am innovative method of impression to restore a maxillo-facial dewfect.3-set-2020Norma Bocca, Gianfranco Gassino, Massimo Carossa, Paola Ceruti, Francesco Bassi
A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification24-ago-2020Cristiana Bianco, Serena Pelusi, Guido Alessandro Baselli, Irene Zanoni, Alice Taliento, Paola Dongiovanni, Raffaela Rametta, Vittorio Borroni, Alessandro Federico,Umberto Vespasiani Gentilucci, Roberta D’Ambrosio, Elisabetta Bugianesi, Salvatore Petta, Luca Miele, Helen L. Reeves, Anna Ludovica Fracanzani, Giorgio Soardo, Daniele Prati, Luca Valenti
Immunological and virological markers during pegylated interferon therapy in HDV chronic hepatitis: any predictor of response?24-ago-2020Antonella Olivero, Gian Paolo Caviglia, Rossella Fontana, Maria Lorena Abate, Chiara Rosso, Giulia Troshina, Elisabetta Bugianesi, Giorgio Maria Saracco, Mario Rizzetto, Grazia Niro, Antonina Smedile, Alessia Ciancio
Macrophage markers do not add to prediction of liver fibrosis by transient elastography in patients with non-alcoholic fatty liver disease24-ago-2020Konstantin Kazankov, Chiara Rosso, Ramy Younes, Hannes Hagstrom, Holger J Moller, Per Stal, Elisabetta Bugianesi, Henning Gronbek
Interplay between metabolic derangement, biomarkers of collagen remodelling and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease24-ago-2020Chiara Rosso, Ramy Younes, Diana Leeming Rambabu Surabattula, Gian Paolo Caviglia, Melania Gaggini, Angelo Armandi, Antonella Olivero, Maria Lorena Abate, Amalia Gastaldelli, Detlef Schuppan, Elisabetta Bugianesi
Serum cytokeratin-19 fragments (CYFRA 21-1) for the prediction of overall survival in patients with hepatocellular carcinoma24-ago-2020Gian paolo Caviglia, Antonella Olivero, Michela Ciruolo, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Maria Lorena Abate, Alessandra Risso, Ramy Younes, Antonina Smedile, Giorgio Maria Saracco, Elisabetta Bugianesi, Silvia Gaia
Insulin secretion is an independent predictor of hepatic ballooning in non-diabetic fatty liver disease.24-ago-2020Ramy Younes, Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, Antonella Olivero, Maria Lorena Abate, Elisabetta Bugianesi
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 2.199

Scopri

Data di pubblicazione
Per editore
Per lingua
Accesso al fulltext
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2020